Note: Not all species have been tested for usefulness with this product. Only those species listed have been tested. We cannot make any guarantees about additional reactivities which may or may not occur.
This antibody reacts with the human and mouse proteins. Other species have not been tested.
Applications:
Uses:
NB600-1384 has been shown to work on human malignant brain tumors, breast cancer, leukemia samples, and murine cells. LC3-I is seen at ~18 kDa and LC3-II at ~16 kDa.
Dilutions:
immunohistochemistry 1:2000,
immunofluorescence 1:2000,
Western Blot 1:3000,
Immunocytochemistry 1:2000
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Products are guaranteed for 6 months from date of receipt, except for peptides and proteins which are guaranteed for 3 months.
Autophagy is a process of intracellular bulk degradation in which cytoplasmic components, including organelles, are sequestered within double-membrane vesicles that deliver the contents to the lysosome/vacuole for degradation. During macroautophagy, the sequestering vesicles, termed autophagosomes, fuse with the lysosome or vacuole resulting in the delivery of an inner vesicle (autophagic body) into the lumen of the degradative compartment. There are 16 proteins participating in the autophagy pathway in humans. The autophagy protein LC3, a mammalian homologue of Atg8, was originally identified as microtubule-associated protein 1 light chain 3. It is a component of both the MAP1A and MAP1B microtubule-binding domains and the heavy-chain independent regulation of LC3 expression may modify MAP1 microtubule-binding activity during development. LC3 is the only known mammalian protein identified that stably
associates with the autophagosome membranes. LC3-I is cytosolic and LC3-II is membrane bound and enriched in the autophagic vacuole fraction. The detection of LC3-I to LC3-II conversion is a useful and sensitive marker for distinguishing autophagy in mammalian cells.
Wei J, Fujita M, Nakai M, et al. Protective Role of Endogenous Gangliosides for Lysosomal Pathology in a Cellular Model of Synucleinopathies. Am J Pathol 2009;174(5):1891-1909. [pubmed: 19349362 ]
Hiroshi Aoki, Yasunari Takada, Seiji Kondo, Raymond Sawaya, Bharat Aggarwal, Yasuko Kondo, Evidence That Curcumin Suppresses the Growth of Malignant Gliomas In Vitro In Vivo Through Induction of Autophagy: Role of Akt ERK Signaling Pathway, Mol Pharmacol. 2007 Mar 29; [Epub ahead of print]
Tafani, M., Schito, L., Anwar, T., et al. Induction of Autophagic Cell Death by a Novel Molecule is Increased by Hypoxia. Autophagy. November 16, 2008; 4:8, 1042-1053.
Gao M, Yeh PY, Lu Y-S, et al. OSU-03012, a Novel Celecoxib Derivative, Induces Reactive Oxygen Species-Related Autophagy in Hepatocellular Carcinoma. Cancer Res 2008;68(22):9348-9357.
Pyo, J., Nah, J., Kim, H., et al. Compensatory activation of ERK1/2 in Atg5-deficient mouse embryo fibroblasts suppresses oxidative stress-induced cell death. Autophagy. April 2008; 4:3, 315-321.